SEQUENT SCIENTIFIC
|
The Current P/E Ratio of SEQUENT SCIENTIFIC is 94.27.
| Share Price | ₹207.3 | Apr 29,2026 |
| Market Cap | ₹9,056.9 Cr | |
| Earnings-TTM | ₹96.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 94.27x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SEQUENT SCIENTIFIC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹9,056.9 Cr] as on Apr 29,2026
(/) Earnings [ ₹96.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 94.27x ]
Thus, for SEQUENT SCIENTIFIC , the investors are currently willing to pay 94.27 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SEQUENT SCIENTIFIC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SEQUENT SCIENTIFIC over the last five years.
Historical PE (Price/Earnings) ratio chart of SEQUENT SCIENTIFIC
PE Ratio Performance Analysis for SEQUENT SCIENTIFIC
- SEQUENT SCIENTIFIC 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 58.69x.
- SEQUENT SCIENTIFIC 's operated at median p/e ratio of 62.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SEQUENT SCIENTIFIC 's p/e ratio peaked in Mar2025 at 149.64x.
- SEQUENT SCIENTIFIC 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does SEQUENT SCIENTIFIC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SEQUENT SCIENTIFIC | 96.07 | 94.27 | 9,056.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 38.80 | 426,830.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 69.98 | 173,484.0 |
| CIPLA LTD | 4,544.70 | 23.40 | 106,357.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.01 | 143,166.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 20.15 | 111,018.0 |
| MANKIND PHARMA LTD | 1,796.65 | 51.81 | 93,076.3 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.57 | 91,607.5 |
| LUPIN LTD | 4,669.18 | 22.63 | 105,650.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 23.09 | 81,109.0 |
| ABBOTT INDIA LTD | 1,524.13 | 35.53 | 54,152.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SEQUENT SCIENTIFIC 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.57x |
| Max industry PE | 94.27x |
| Median industry PE | 35.53x |
| Average industry PE | 41.93x |
You may also like the below Video Courses